CD AND M REMEDIES PRIVATE LIMITED

S-Adenosyl-L-Methionine Tablets 400 Mg Hepcn is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing S-Adenosyl-L-Methionine 400 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this hepatoprotective supplement tablet is supplied in 10 Tablets per strip (outer pack size as supplied) export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable liver support formulation medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this SAMe tablet for liver health a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: S-Adenosyl-L-Methionine 400 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10 Tablets per strip (outer pack size as supplied) packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Hepatoprotective Supplement (Liver Support)
• Dosage Form: Tablets
• Pack Size: 10 Tablets per strip (outer pack size as supplied)
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1018

Fungal Diastase Pepsin With B-Complex Sugar Free Syrup Cd-Zyme SF is a pharmacopeia-grade syrup formulation manufactured by CD&M Remedies, containing Diastase 50 mg + Pepsin 10 mg + B-Complex vitamins (per 5 ml, sugar-free). Formulated to Indian Pharmacopoeia (IP) specifications, this sugar-free digestive enzyme syrup formulation is supplied in 200 ml export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable B-complex digestive support medication for diabetics for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this appetite and digestion support syrup a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Diastase 50 mg + Pepsin 10 mg + B-Complex vitamins (per 5 ml, sugar-free)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in syrup form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 200 ml packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Digestive Enzyme Syrup (Sugar-Free Nutraceutical Formulation)
• Dosage Form: Syrup
• Pack Size: 200 ml
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1015

Fungal Diastase Pepsin With B-Complex Syrup Cd-Zyme is a pharmacopeia-grade syrup formulation manufactured by CD&M Remedies, containing Diastase 50 mg + Pepsin 10 mg + B-Complex vitamins (per 5 ml). Formulated to Indian Pharmacopoeia (IP) specifications, this digestive enzyme syrup formulation is supplied in 200 ml export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable B-complex digestive support medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this appetite and digestion support syrup a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Diastase 50 mg + Pepsin 10 mg + B-Complex vitamins (per 5 ml)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in syrup form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 200 ml packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Digestive Enzyme Syrup (Nutraceutical Formulation)
• Dosage Form: Syrup
• Pack Size: 200 ml
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1014

Telmisartan And Cilnidipine Tablets Cdsar-Ln is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Telmisartan IP 40 mg + Cilnidipine IP 10 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this ARB calcium channel blocker combination tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable hypertension dual-mechanism therapy medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this telmisartan cilnidipine fixed-dose formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Telmisartan IP 40 mg + Cilnidipine IP 10 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Cardiovascular Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1013

Telmisartan Tablets IP 40 Mg Cdsar-40 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Telmisartan IP 40 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this angiotensin receptor blocker tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable hypertension management medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this antihypertensive tablet formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Telmisartan IP 40 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Cardiovascular Medication (Angiotensin Receptor Blocker)
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1010

Rabeprazole Sodium Enteric Coated And Domperidone Sustained Release Capsules Cdrab is a pharmacopeia-grade capsules formulation manufactured by CD&M Remedies, containing Rabeprazole Sodium IP 20 mg (enteric coated) + Domperidone IP 30 mg (sustained release). Formulated to Indian Pharmacopoeia (IP) specifications, this proton pump inhibitor prokinetic combination capsule is supplied in 10x10 Capsules export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable acid reflux and gastric motility medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this enteric-coated gastrointestinal formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Rabeprazole Sodium IP 20 mg (enteric coated) + Domperidone IP 30 mg (sustained release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in capsules form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Capsules packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Gastrointestinal Medication (PPI + Prokinetic Combination)
• Dosage Form: Capsules
• Pack Size: 10x10 Capsules
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1009

Glimepiride And Metformin Hcl Sustained Release Tablets Cdpride-M2 Forte is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Glimepiride IP 2 mg + Metformin Hydrochloride IP 1000 mg (sustained release). Formulated to Indian Pharmacopoeia (IP) specifications, this high-dose antidiabetic combination tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable type 2 diabetes intensive therapy medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this sulfonylurea biguanide combination formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Glimepiride IP 2 mg + Metformin Hydrochloride IP 1000 mg (sustained release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Anti-Diabetic Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1007

Glimepiride Voglibose And Metformin Hcl Sustained Release Tablets Cdpride-Mv2 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Glimepiride IP 2 mg + Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (sustained release). Formulated to Indian Pharmacopoeia (IP) specifications, this triple combination antidiabetic tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable comprehensive type 2 diabetes therapy medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this three-drug fixed-dose formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Glimepiride IP 2 mg + Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (sustained release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Anti-Diabetic Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1008

Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M2 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Metformin Hydrochloride IP 500 mg (prolonged release) + Glimepiride IP 2 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this antidiabetic combination tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable type 2 diabetes management medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this glimepiride metformin fixed-dose formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Metformin Hydrochloride IP 500 mg (prolonged release) + Glimepiride IP 2 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Anti-Diabetic Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1006

Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M1 Forte is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Glimepiride IP 1 mg + Metformin Hydrochloride IP 1000 mg (prolonged release). Formulated to Indian Pharmacopoeia (IP) specifications, this high-strength antidiabetic combination tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable type 2 diabetes fixed-dose therapy medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this glimepiride metformin combination formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Glimepiride IP 1 mg + Metformin Hydrochloride IP 1000 mg (prolonged release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Anti-Diabetic Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1005

Glimepiride And Metformin Hydrochloride Sustained Release Tablets Cdpride-M1 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Glimepiride IP 1 mg + Metformin Hydrochloride IP 500 mg (sustained release). Formulated to Indian Pharmacopoeia (IP) specifications, this sulfonylurea-biguanide combination tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable type 2 diabetes combination therapy medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this fixed-dose antidiabetic tablet a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Glimepiride IP 1 mg + Metformin Hydrochloride IP 500 mg (sustained release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Anti-Diabetic Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1004

Metoprolol Succinate Prolonged Release Tablets IP Cdmet-Xr-50 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Metoprolol Succinate IP 47.5 mg (equivalent to Metoprolol Tartrate 50 mg, prolonged release). Formulated to Indian Pharmacopoeia (IP) specifications, this beta-blocker antihypertensive tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable cardiovascular management medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this prolonged release metoprolol formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Metoprolol Succinate IP 47.5 mg (equivalent to Metoprolol Tartrate 50 mg, prolonged release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Cardiovascular Medication (Beta-Blocker / Antihypertensive)
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1003

Metformin Hydrochloride Prolonged Release 500 Mg Tablets Cd Formin-500 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Metformin Hydrochloride IP 500 mg (prolonged release). Formulated to Indian Pharmacopoeia (IP) specifications, this anti-diabetic tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable type 2 diabetes management medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this biguanide antidiabetic formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Metformin Hydrochloride IP 500 mg (prolonged release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Anti-Diabetic Medication (Biguanide)
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1001

Rosuvastatin Tablets IP 10 Mg Rowakar 10 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Rosuvastatin IP 10 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this statin lipid-lowering tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable cholesterol management medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this rosuvastatin formulation for cardiovascular risk reduction a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Rosuvastatin IP 10 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Lipid-Lowering Medication (Statin)
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1020

Ursodeoxycholic Acid Tablets IP 300 Mg Udi-Cn is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Ursodeoxycholic Acid IP 300 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this bile acid hepatoprotective tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable liver and gallbladder support medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this ursodeoxycholic acid formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Ursodeoxycholic Acid IP 300 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Hepatoprotective Medication (Bile Acid)
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1019

Telmisartan And Hydrochlorothiazide Tablets IP Cdsar-H is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Telmisartan IP 40 mg + Hydrochlorothiazide IP 12.5 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this ARB diuretic combination tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable hypertension management combination medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this telmisartan hydrochlorothiazide fixed-dose formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Telmisartan IP 40 mg + Hydrochlorothiazide IP 12.5 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Cardiovascular Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1012

Telmisartan And Amlodipine Tablets IP Cdsar-Am is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Telmisartan IP 40 mg + Amlodipine 5 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this ARB calcium channel blocker combination tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable hypertension combination therapy medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this telmisartan amlodipine fixed-dose formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Telmisartan IP 40 mg + Amlodipine 5 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Cardiovascular Combination Medication
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1011

Rabeprazole Sodium And Domperidone Sustained Release Capsules Crab-Dsr is a pharmacopeia-grade capsules formulation manufactured by CD&M Remedies, containing Rabeprazole Sodium IP 20 mg (enteric coated) + Domperidone IP 30 mg (sustained release). Formulated to Indian Pharmacopoeia (IP) specifications, this proton pump inhibitor prokinetic combination capsule is supplied in 10x10 Capsules export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable acid reflux gastric motility medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this enteric-coated gastrointestinal formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Rabeprazole Sodium IP 20 mg (enteric coated) + Domperidone IP 30 mg (sustained release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in capsules form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Capsules packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Gastrointestinal Medication (PPI + Prokinetic Combination)
• Dosage Form: Capsules
• Pack Size: 10x10 Capsules
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1016

Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr is a pharmacopeia-grade capsules formulation manufactured by CD&M Remedies, containing Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release). Formulated to Indian Pharmacopoeia (IP) specifications, this PPI prokinetic combination capsule is supplied in 10x10 Capsules export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable acid reflux and motility disorder medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this enteric-coated levosulpiride rabeprazole formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release)
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in capsules form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Capsules packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Gastrointestinal Medication (PPI + Prokinetic Combination)
• Dosage Form: Capsules
• Pack Size: 10x10 Capsules
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1017

Voglibose Tablets I.P. 0.3 Mg Cdbose 0.3 is a pharmacopeia-grade tablets formulation manufactured by CD&M Remedies, containing Voglibose IP 0.3 mg. Formulated to Indian Pharmacopoeia (IP) specifications, this alpha-glucosidase inhibitor tablet is supplied in 10x10 Tablets export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable postprandial blood glucose control medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this anti-diabetic tablet formulation a dependable addition to a pharmaceutical importer's product portfolio.

Features:

• Composition: Voglibose IP 0.3 mg
• Manufactured to Indian Pharmacopoeia (IP) standards for consistent quality
• Available in tablets form for ease of storage, handling, and dispensing
• Supplied by CD&M Remedies, an established pharmaceutical manufacturer and exporter
• Export-ready 10x10 Tablets packing designed for bulk international shipment
• Suitable for wholesale distribution to pharmacies, hospitals, and healthcare institutions

Attributes:

• Brand / Seller: CD&M Remedies
• Product Category: Anti-Diabetic Medication (Alpha-Glucosidase Inhibitor)
• Dosage Form: Tablets
• Pack Size: 10x10 Tablets
• Pharmacopeial Standard: Indian Pharmacopoeia (IP)
• Product Code: 1002